支架球囊导管冠状动脉内给药途径处理支架置入后无复流现象一例
祝金明,纳顺达来,赵雷,李淑梅
摘要(Abstract)：
<正>Kloner等[1]最早于1974年在动物实验中描述无复流现象。Eeckhout等[2]根据无复流的具体特征和发生机制,分为实验性无复流、心肌梗死再灌注无复流和血管造影无复流。Galiuto等[3]根据形态学和功能学的研究,将其分为"解剖
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 祝金明,纳顺达来,赵雷,李淑梅
参考文献(References)：
- [1]Kloner RA,Ganote CE,Jennings RB.The"no-reflow"phenomenon after temporary coronary occlusion in the dog.J Clin Invest,1974,54:1496-1508.
- [2]Eeckhout E,Kern MJ.The coronary no-reflow phenomenon:a review of mechanisms and therapies.Eur Heart J,2001,22:729-739
- [3]Galiuto L.Optimal therapeutic strategies in the setting of post-infarct no reflow:the need for a pathogenetic classification.Heart,2004,90:123-125.
- [4]Son JW,Kim JS,Lee JM,et al.Percutaneous cardiopulmonary support in refractory no-reflow with cardiogenic shock after coronary stenting in acute myocardial infarction.Yonsei Med J,2010,51:599-601,
- [5]Lim SY,Bae EH,Jeong MH,et al.Effect of combined intracoronary adenosis and nicordial on no-reflow phenomenon during percutaneous coronary intervention.Circ J,2004,68:928-932.
- [6]Parham WA,Bouhasin A,Ciaramita JP,et al.Coronary hyperemic dose responses of intracoronary sodium nitroprusside.Circulation,2004,109:1236-1243.
- [7]Harding SA.The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention.Heart,2006,92:1635-1638.
- [8]Umemura S,Nakamura S,Sugiura T,et al.The effect of verapamil on the restoration of myocardial perfusion and functional recovery in patients with angiographic no-reflow after primary percutaneous coronary intervention.Nucl Med Commun,2006,27:247-254.
- [9]Huang RI,Patel P,Walinsky P,et al.Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention.Catheter Cardiovasc Interv,2006,68:671-676.
- [10]赵鹏,姜铁民,赵季红,等.经微导管注射维拉帕米对急诊PCI术中无复流现象的疗效.临床荟萃,2009,24:19-22.